DocuSign Stock Plunges on Soft Outlook

The company also said it expects subscription revenue growth to slow, forecasting a range of $2.39 billion to $2.41 billion.

Billings, which reflect new-customer sales, subscription renewals and add-on sales for existing customers, are expected to come in between $2.71 billion and $2.73 billion, also a substantial slowdown from 2021.

The company warned in December that its growth would likely be hampered as people returned to more normalized working and buying patterns as the pandemic faded. The company said at the time that it would invest in increasing its sales efforts, increase marketing spending and spend more on product innovation.

DocuSign fits into a category of companies that made working from home easier to manage and benefitted as businesses adapted to remote and paperless environments. But its business has taken a hit as the pandemic fades and more offices begin calling their employees back to in-person work.

Its share price tripled in 2020. It fell almost 32% last year and is down 38.4% so far this year, before Friday’s premarket drop. The stock was last seen trading 17% lower at $77.91 a share.

Despite the forecasted slowdown, Chief Executive

Dan Springer

said the company’s digital-signature business will continue to grow.

“As people begin to return to the office, they are not returning to paper,” Mr. Springer said. “eSignature and the broader Agreement Cloud will only continue to gain prominence in the evolving Anywhere Economy.”

The worse-than-expected guidance came even as DocuSign topped analysts’ expectations for revenue in the fiscal fourth quarter. The company reported adjusted earnings of 48 cents a share on revenue of $580.8 million. Analysts were expecting adjusted earnings of 48 cents a share on revenue of $562 million.

DocuSign also said its board has authorized it to buy back $200 million worth of shares. At the same time, the company said Chief Revenue Officer Loren Alhadeff intends to resign.

Still, analysts at Oppenheimer on Friday removed their $250 price target on the stock and downgraded DocuSign to perform from outperform.

“The guidance shows that the challenges seen then with respect to sales execution and resetting post-Covid consumption patterns remain near- to medium-term headwinds,” the analysts wrote.

Write to Will Feuer at [email protected]